Literature DB >> 16373649

Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.

Egle Corrado1, Manfredi Rizzo, Rosalba Tantillo, Ida Muratori, Francesca Bonura, Giustina Vitale, Salvatore Novo.   

Abstract

BACKGROUND AND
PURPOSE: It is still in debate whether the evaluation of markers of infection and inflammation may be of importance for cerebrovascular and cardiovascular prevention, and we aimed to investigate this field in a prospective 5-year clinical follow-up study in patients with early stages of atherosclerosis.
METHODS: We studied 668 subjects divided in 3 groups according to the results of carotid ultrasound examination: (1) normal subjects, if intima-media thickness (IMT) was <0.9 mm; (2) with IMT, if IMT was between 0.9 and 1.5 mm; and (3) with asymptomatic carotid plaque, if IMT was >1.5 mm. Traditional cardiovascular risk factors were investigated, and laboratory analysis included measurement of plasma lipids, fibrinogen, C-reactive protein, IgG antibodies for helicobacter pylori (HP), cytotoxic HP, cytomegalovirus, and chlamydia pneumoniae.
RESULTS: Cerebrovascular or cardiovascular events were registered in 18% of patients during the follow-up, and at multivariate analysis we found that the high levels of fibrinogen (P<0.0001) and C-reactive protein (P=0.014), the seropositivity to cytotoxic HP (P=0.001) and chlamydia pneumoniae (P=0.026), the presence of IMT or asymptomatic carotid plaque (P<0.0001), and the total burden of infections (P<0.0001) were the variables predictive of the clinical events.
CONCLUSIONS: Beyond traditional cardiovascular risk factors, markers of inflammation and infections seem to significantly influence the occurrence of cerebrovascular and cardiovascular events in patients with baseline asymptomatic carotid lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373649     DOI: 10.1161/01.STR.0000198813.56398.14

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

Review 1.  Extragastric diseases associated with Helicobacter pylori infection.

Authors:  Karen J Goodman; Stephanie L Joyce; Kathleen P Ismond
Journal:  Curr Gastroenterol Rep       Date:  2006-12

Review 2.  Inflammatory markers and stroke.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

3.  Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages.

Authors:  Sabrina Uda; Stefano Spolitu; Fabrizio Angius; Maria Collu; Simonetta Accossu; Sebastiano Banni; Elisabetta Murru; Francesca Sanna; Barbara Batetta
Journal:  J Lipid Res       Date:  2013-08-16       Impact factor: 5.922

4.  Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM.

Authors:  Yann Gouëffic; Susan Potter-Perigo; Christina K Chan; Pamela Y Johnson; Kathleen Braun; Steven P Evanko; Thomas N Wight
Journal:  Atherosclerosis       Date:  2006-12-14       Impact factor: 5.162

Review 5.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

6.  Viral and parasitic pathogen burden and the association with stroke in a population-based cohort.

Authors:  Brad D Pearce; Anna Bracher; Jeffrey L Jones; Deanna Kruszon-Moran
Journal:  Int J Stroke       Date:  2017-09-15       Impact factor: 5.266

7.  Atherosclerosis, inflammation and Chlamydia pneumoniae.

Authors:  Giovanni Fazio; Maria Giovino; Alessandro Gullotti; Daniela Bacarella; Giuseppina Novo; Salvatore Novo
Journal:  World J Cardiol       Date:  2009-12-31

Review 8.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

Review 9.  Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke.

Authors:  Jerzy Krupinski; Marta M Turu; Mark Slevin; José Martínez-González
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

10.  Risk factors for contrast induced nephropathy: a study among Italian patients.

Authors:  Salvatore Evola; Monica Lunetta; Francesca Macaione; Giuseppe Fonte; Gaspare Milana; Egle Corrado; Francesca Bonura; Giuseppina Novo; Enrico Hoffmann; Salvatore Novo
Journal:  Indian Heart J       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.